Subsequently, several global lactylome profiles have demonstrated that Kla is a prevalent type of modification and is generally upregulated in most cancers, such as ocular melanoma [14, 29], hepatocellular carcinoma [19, 20], colorectal cancer [53], and gastric cancer [28]. The gene discussed is KL; the disease is hepatocellular carcinoma.